Valuation (66%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 11.35 | N/A |
| PEG Ratio (TTM) | -1.98 | N/A |
| P/S Ratio (TTM) | 2.83 | N/A |
| P/B Ratio (TTM) | 1.09 | N/A |
| P/FCF Ratio (TTM) | 7.82 | N/A |
| Price to 5YR AVG Earnings Ratio | 11.83 | N/A |
| Price to 5YR AVG FCF Ratio | 10.07 | N/A |
Profitability (70%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 1.21% | N/A |
| ROE (TTM) | 10.18% | N/A |
| Net Profit Margin (TTM) | 24.78% | N/A |
| ROIC 5YR AVG | 59.57% | N/A |
Growth (73%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 10.53% | 7.30% | 8.28% |
| Revenue | 0.31% | 9.03% | 5,021.47% |
| Net Income | 10.25% | 12.65% | 11.00% |
| Cash Flow | 15.98% | 17.16% | 9.62% |
Health (61%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 11.72 | N/A |
| Quick Ratio (TTM) | 11.72 | N/A |
| D/E Ratio (TTM) | 0.96 | N/A |
| Interest Coverage (TTM) | 2.73 | N/A |
| Piotroski F-Score | 6 | N/A |
| Altman Z-Score | 0.55 | N/A |
| LTL to 5YR AVG FCF | 5.96 | N/A |
| Shares Outstanding Growth 5YR AVG | 4.32% | N/A |